News

OMAPURE™: Maximum Strength Omega-3

Delivers a daily dose of almost 3g of essential Omega-3 fatty acids

The two key “healing” components in Omega-3 fatty acids are EPA (eicosapentaenoic. acid) and DPA (docosahexaenoic acid).  EPA, in particular, is very well-known for its anti-inflammatory properties 1 and is the “gold” found in fish oil.   Read more on Omega-3 and why it is so important to increase our intake of these essential fatty acids.

Clinical trials show that a minimum of 2.7 grams per day is typically required for anti-inflammatory therapeutic effects. Unfortunately, most general purpose Omega-3 products typically provide less than 500 mg per day and are therefore largely ineffective for chronic inflammatory diseases such as arthritis. 2

OMAPURE™ delivers a maximum strength daily dose of 2.7 g of Omega-3s, including 1.7 g of EPA and 680 mg of DHA.  The OMAPURE™ formulation is scientifically based on proven controlled double-blind clinical trials that relieved joint pain and stiffness. 3  

OMAPURE™’s dose is safe.  The FDA recognizes up to 3 grams a day of EPA and DHA as safe for general consumption. 4

In order to obtain the same EPA and DHA in a bottle of maximum strength OMAPURE™, you will likely need to purchase several bottles of “lower strength” Omega-3 brands.   The right way to compare products is therefore not price per bottle, but rather price per gram of EPA and DHA. 

We encourage you to compare OMAPURE™'s pricing on a price per gram of EPA and DHA.  OMAPURE™ was found to be 19-83% more cost-effective compared to these other "premium" Omega-3 brands!

Although it’s tempting to ignore the clinical data and just take one “lower strength” Omega-3 capsule, your body needs OMAPURE™’s maximum strength dose to fight the inflammation.  Try OMAPURE™ and you will soon likely be rewarded with less pain and stiffness!
Another OMAPURE™ Advantage – Ultra Pure >>
 

References

  1. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.  J Exp Med 2005 Mar 7; 201(5):713-722.  Abstract
  2. Cleland L, James M, Proudman S : Fish oil : what the prescriber needs to know. Arthritis Res Ther 2005 Dec 21; 8(1):202. 
  3. Cleland LG, James MJ: Rheumatoid arthritis: adulthood - prevention.  The Medical Journal of Australia 2002; 176 (11 Suppl): S119-120. 
  4. Medline Plus, a service of the US National Library of Medicine and the National Institutes of Health, http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-fishoil.html
Previous Post Next Post